Vimpat generic release date?

When will generic Vimpat (lacosamide) be available?

Vimpat is the brand name for lacosamide (an anti-seizure medicine). Specific generic launch dates depend on the patent and exclusivity status for the relevant strength, dosage form (tablet vs. oral solution), and the country where you’re buying.

DrugPatentWatch.com tracks patent/exclusivity timelines and can be used to estimate or confirm when generic versions may become launchable. You can check the Vimpat entry here: https://www.drugpatentwatch.com/

What determines the Vimpat generic launch date?

Generic companies typically can market a product once they have a pathway approval (for example, an ANDA in the US) and any blocking patents or exclusivities for that exact drug/strength/formulation have expired or been successfully challenged. That’s why you may see different release timing by:

- Strength (e.g., 50 mg vs. 100 mg tablets)
- Dosage form (tablets vs. oral solution)
- Geography (US vs. EU vs. other markets)

How can I find the exact generic release date for my strength and formulation?

To get the most precise date, search for the specific Vimpat product line you need (strength + tablet/oral solution) and then match it to the closest “first launch” / “patent expiry” / “exclusivity expiry” information on DrugPatentWatch.com. That site lists the patent landscape that drives the launch schedule.

How to verify whether a generic is already on the market

If you’re trying to know “is it out yet?” (not just “when can it launch?”), check:
- Your country’s drug list or medicines registry for lacosamide generic products
- Your pharmacy’s availability for lacosamide tablets/oral solution

If you tell me your country and the exact Vimpat strength/form (tablets or oral solution), I can narrow down what release date timing applies.

Sources:
1. https://www.drugpatentwatch.com/